Clinical Trials Directory

Trials / Unknown

UnknownNCT06262152

Sleep Profile of Patients With Septo-optic Dysplasia

Characterization of Sleep Features in Pediatric Patients With Septa-optic Dysplasia

Status
Unknown
Phase
Study type
Observational
Enrollment
45 (estimated)
Sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation · Academic / Other
Sex
All
Age
3 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate sleep of patients with septo-optic dysplasia compared to patients with an isolated disorder of peripheral visual system and patients with corpus callosum agenesis since both visus defict and agenesis of corpus callosum might be present SOD but associated to other features / structural and functional anomalies. Included patients and their caregivers will be asked to compile standardize sleep questionnaires and a sleep screening through an interview will be scheduled. Patients will be asked to wear an actigraph on their non-dominant hand wrist for 7 days.

Detailed description

The primary objective of this study is to evaluate sleep of patients with septo-optic dysplasia compared to patients with an isolated disorder of peripheral visual system and patients with corpus callosum agenesis since both visus defict and agenesis of corpus callosum might be present SOD but associated to other features / structural and functional anomalies. The secondary aims of this study are the following: 1. identify which factors such as clinical and neuroanatomical features including sensory experience influence sleep outcome and how 2. describe melatonin profile of patients with SOD 3. describe sleep EEG of patients with SOD Three groups of patients will be included: * Group A: patients with septo-optic dysplasia * Group B: patients with disorder of peripheral visual system * Group C: patients with Corpus Callosum agenesis This is an observational monocentric study. The procedures in the study that are not included in current clinical practice in the follow-up pathway of the included patients are the following: * administration of standardized sleep questionnaires (Pittsburgh Sleep Quality Index: self-completed questionnaire assessing sleep quality over a 1-month time interval;Epworth Sleepiness Scale: self-completed questionnaire assessing daytime sleepiness; Children sleep habits questionnaire) * 7 days actigraph recording through wearing of Actiwatch spectrum plus at home * Performance of Sleep EEG * Performance of blood and salivary sampling for melatonin dosing (for each subject, one 4 mL blood and one 2 mL saliva samples will be collected at each assessment)

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTActigraphy, blood and salivary sample, and sleep evaluation* For each subject, one 4 mL blood and one 2 mL saliva samples will be collected at each assessment. * 7 days actigraph recording through wearing of Actiwatch spectrum plus at home * Standardized sleep questionnaire administration

Timeline

Start date
2023-12-20
Primary completion
2024-01-20
Completion
2025-05-20
First posted
2024-02-15
Last updated
2024-02-15

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06262152. Inclusion in this directory is not an endorsement.

Sleep Profile of Patients With Septo-optic Dysplasia (NCT06262152) · Clinical Trials Directory